Future studies that administer neutralizing antibodies against IFNAR, other individual IFN subtypes, or other anti- or pro-inflammatory cytokines at different phases of acute virus infection may reveal stage-specific requirements for shaping effector CD8+ T cells, the contraction phase, and the transition to central and effector memory. This evidence concerns the gene IFNA1 and viral infectious disease.